Click here for The Motley Fool’s resources on Coronavirus and the market.
Cannabidiol (CBD) is rising in appeal as people discover about its possible health advantages, which vary from relaxation, pain relief, and battling swelling to treating people with epilepsy.
Unilever ( NYSE: UL) revealed last year that it would be going into the cannabis industry through one of its subsidiaries, Schmidt’s Naturals. The current consumer items business to get in the cannabis fray is Colgate Palmolive ( NYSE: CL)
Colgate purchases Hey there Products
In January, Colgate revealed it would acquire an oral care brand name, Hi Products. The company offers toothpaste, floss, toothbrushes, and other oral hygiene items. One of the factors Colgate is thrilled about the offer is because of Hi Products’ focus on young clients, with what Colgate CEO Noel Wallace calls “distinct on-trend positioning.”
One of the patterns that Hi Products is banking on: hemp-derived CBD. Quickly after the acquisition announcement, Hello Products announced on Feb. 4 that it would be releasing a line of CBD items: mouthwash, toothpaste, and even lip balm which contains CBD.
The company states in its news release that the CBD originates from “hemp grown by partner farms based in the U.S.” Although marijuana remains unlawful in the U.S. at the federal level, hemp-derived CBD items are not, thanks to the farm Costs, and they provide a way for companies to remain on the ideal side of the law.
Image source: Getty Images.
Why it deserves the gamble for Colgate
Entering into a brand-new line of health products is a relatively sure thing for Colgate to make. It currently makes comparable non-CBD items, and adding a new line to its portfolio could potentially tap the company into more youthful markets and help find a new type of client. It’s still far too early to inform how popular CBD oral care items will be and whether they’re any much better than what’s on the market today. For Colgate, it’s most likely a low-risk relocation. Hemp-based CBD is legal, and considering that the products are sold through Hello Products, Colgate’s name won’t straight be connected with marijuana– which could switch off some consumers, as cannabis legislation is still a polarizing topic for many people.
And when it comes to the opportunity, financiers only need to look as far as Charlotte’s Web ( OTC: CWBHF), which offers hemp products, to see the potential that exists. Over the past 12 months, the business produced more than $93 million in profits, and its items are sold in more than 9,000 locations across the nation. Charlotte’s Web isn’t in oral care, but it does focus on health and health products, which have actually proven to be popular.
What does this mean for financiers?
Entering marijuana items, specifically oral care products, most likely isn’t going to provide Colgate’s numbers much of a bump in sales. The company published $157 billion in income in 2019, so producing even a 1%enhancement would require profits of nearly $160 million. For oral care, the marketplace may not be there right now. Brightfield Group estimates that the overall CBD market was worth more than $4 billion in 2019, however that consists of both hemp and nonhemp items. And even though it expects the U.S. CBD market to be worth more than $24 billion by 2025, it’s uncertain how big a slice of that pie oral care might claim.
If you were going to purchase shares of Colgate, its purchase of Hello Products most likely won’t impact your decision. It’s too early to know the impact of this acquisition and whether the products will succeed in generating any considerable revenue development. The crucial takeaway from this is Colgate’s relocation into cannabis in any kind, recommending that there may be some interest in the industry which it might result in relocations down the roadway must full legalization of cannabis in the U.S. make more development.
It’s a sign that there might be some more potential cannabis acquisitions this year. A cannabis stock like Charlotte’s Web, for example, would enable financiers to use the buzz surrounding hemp-derived CBD items.
David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends Charlotte’s Web. The Motley Fool has a disclosure policy.”> disclosure policy”>